Krishna Institute of Medical Sciences Limited share price

Key numbers

Market cap

₹ 32,767 Cr

Current price

₹ 780.15

52-week high / low

₹ 858 / 576

Stock P/E

156.3

Book value

₹ 56.2

Dividend yield

0.00%

ROCE

9.5%

ROE

11.0%

Debt to equity

1.89

Sales growth (3 yrs)

21.3%

Profit growth (3 yrs)

-10.5%

1-year return

7.4%

About Krishna Institute of Medical Sciences Limited

Krishna Institute of Medical Sciences Limited provides medical and health care services under the KIMS Hospitals brand in India. The company offers arthroscopy and shoulder, cardiology, cardiothoracic and cardiovascular, organ transplant, medical and surgical gastroenterology, hepatology, orthopaedic, neurology, neurosurgery, nephrology, urology, oncology, pediatric, neonatology, obstetrics and gynaecology, fertility, dental science, emergency and critical care, vascular, rehabilitation and physiotherapy services. It also provides pulmonology, diagnostic and imaging, ophthalmology, ENT, rheumatology and clinical immunology, internal medicine, interventional radiology, diabetology, endocrinology, general surgery, infectious disease, dermatology, thoracic surgery, psychiatry, plastic and reconstructive surgery, transfusion medicine, clinical psychology, anesthesiology, and tele medicine services. In addition, the company operates clinical immunology allergy, bone marrow transplantation, hair transplant, andrology, fertility, alzheimer, arthroscopy, bone and joint, breast, dialysis, female urology, IUI, IVF, joint replacement, kidney health and transplant, ICU, spine, stroke,…

Quarterly results

Consolidated figures in ₹ crores

Concall summary (2026-08-08)

AI summary of the earnings call transcript · tone: Positive · source document

Guidance & outlook

• So, it could be anywhere between, somewhere we are expecting it to be anywhere around INR 85,000, around that number, INR 80,000 to INR 85,000.
• So, there is nothing much different, even though initially we KIMS Hospitals August 04, 2026 expected around INR 75,000, but the thing is that as we placed as a strategy, we placed ourselves as more of a quaternary care hospital doing very complex kind of procedures, very niche kind of procedures.

Growth & demand

• Consolidated EBITDA pre-Ind AS and excluding other income of INR 206 crores, a growth of 10.2% on year-on-year and a growth of 10% on quarter-on-quarter basis.
• IP volumes, 72,493 grew by 26.6% year-on-year and 14% on quarter-on-quarter basis.

Margins & costs

• EBITDA of INR 240 crore, a growth of 20.1% on year-on-year and 10.9% on quarter-on-quarter basis.
• EBITDA margin at 20.1% versus 20.27% in Quarter 1 Financial Year '26 and 19.9% in Quarter 4 Financial Year '26.

Capex & expansion

• Cash and cash equivalents includes cash, bank balance deposits with maturity less than 12 months and investment in mutual funds at INR 505 crore as on 30th June 2026.
• And you all know that last quarter we have inaugurated the new facility of Kondapur, and we are now doing a 50% growth within a quarter.

Balance sheet & cash

• In line with our commitment to financial prudence, INR 1,100 crores of these proceeds have already been utilized to reduce our debt.
• So, as of 31st of March '26, at the start of the financial year, the debt position was INR 3,250 crore, which has reduced to INR 2,570 crore as on 30th June.

Peers in Medical Care Facilities

• Apollo Hospitals Enterprise Limited
• Max Healthcare Institute Limited
• Manipal Health Enterprises Limited
• Aster DM Quality Care Limited
• Fortis Healthcare Limited
• Global Health Limited
• Narayana Hrudayalaya Limited
• Rainbow Children's Medicare Limited
• Park Medi World Limited
• Yatharth Hospital & Trauma Care Services Limited